Table of Content


1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights

2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunity
4.3. Global Central Lab Market Forecast
4.4. Global Central Lab Market Outlook

5. Market Outlook
5.1. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
5.2. Strategies Adopted by Top 3 Players

6. Global Central Lab Market Analysis, by Product
6.1. Introduction
6.2. Global Central Lab Market Value Share Analysis, by Product
6.3. Global Central Lab Market Forecast, by Product
6.3.1. Genetic Services
6.3.2. Biomarker Services
6.3.3. Microbiology Services
6.3.4. Anatomic Pathology/Histology
6.3.5. Specimen Management & Storage
6.3.6. Special Chemistry Services
6.3.7. Clinical Research & Trial Services
6.3.8. Others
6.4. Global Central Lab Market Analysis, by Product
6.5. Global Central Lab Market Attractiveness Analysis, by Product

7. Global Central Lab Market Analysis, by End-user
7.1. Introduction
7.2. Global Central Lab Market Value Share Analysis, by End-user
7.3. Global Central Lab Market Forecast, by End-user
7.3.1. Pharmaceutical Companies
7.3.2. Biotechnology Companies
7.3.3. Academic & Research Institutes
7.4. Global Central Lab Market Analysis, by End-user
7.5. Global Central Lab Market Attractiveness Analysis, by End-user

8. Global Central Lab Market Analysis, by Region
8.1. Global Central Lab Market Forecast, by Region
8.1.1. North America
8.1.2. Europe
8.1.3. Asia Pacific
8.1.4. Latin America
8.1.5. Middle East & Africa

9. North America Central Lab Market Analysis
9.1. North America Central Lab Market Overview
9.2. North America Central Lab Market Value Share and Attractiveness Analysis, by Country
9.3. North America Central Lab Market Forecast, by Country
9.3.1. U.S.
9.3.2. Canada
9.4. North America Central Lab Market Value Share and Attractiveness Analysis, by Product
9.5. North America Central Lab Market Forecast, by Product
9.5.1. Genetic Services
9.5.2. Biomarker Services
9.5.3. Microbiology Services
9.5.4. Anatomic Pathology/Histology
9.5.5. Specimen Management & Storage
9.5.6. Special Chemistry Services
9.5.7. Clinical Research & Trial Services
9.5.8. Others
9.6. North America Central Lab Market Value Share and Attractiveness Analysis, by End-user
9.7. North America Central Lab Market Forecast, by End-user
9.7.1. Pharmaceutical Companies
9.7.2. Biotechnology Companies
9.7.3. Academic & Research Institutes

10. Europe Central Lab Market Analysis
10.1. Europe Central Lab Market Overview
10.2. Europe Central Lab Market Value Share and Attractiveness Analysis, by Country/Sub-region
10.3. Europe Central Lab Market Forecast, by Country/Sub-region
10.3.1. Germany
10.3.2. France
10.3.3. U.K.
10.3.4. Italy
10.3.5. Spain
10.3.6. Rest of Europe
10.4. Europe Central Lab Market Value Share and Attractiveness Analysis, by Product
10.5. Europe Central Lab Market Forecast, by Product
10.5.1. Genetic Services
10.5.2. Biomarker Services
10.5.3. Microbiology Services
10.5.4. Anatomic Pathology/Histology
10.5.5. Specimen Management & Storage
10.5.6. Special Chemistry Services
10.5.7. Clinical Research & Trial Services
10.5.8. Others
10.6. Europe Central Lab Market Value Share and Attractiveness Analysis, by End-user
10.7. Europe Central Lab Market Forecast, by End-user
10.7.1. Pharmaceutical Companies
10.7.2. Biotechnology Companies
10.7.3. Academic & Research Institutes

11. Asia Pacific Central Lab Market Analysis
11.1. Asia Pacific Central Lab Market Overview
11.2. Asia Pacific Central Lab Market Value Share and Attractiveness Analysis, by Country/Sub-region
11.3. Asia Pacific Central Lab Market Forecast, by Country/Sub-region
11.3.1. Japan
11.3.2. China
11.3.3. India
11.3.4. Australia & New Zealand
11.3.5. Rest of Asia Pacific
11.4. Asia Pacific Central Lab Market Value Share and Attractiveness Analysis, by Product
11.5. Asia Pacific Central Lab Market Forecast, by Product
11.5.1. Genetic Services
11.5.2. Biomarker Services
11.5.3. Microbiology Services
11.5.4. Anatomic Pathology/Histology
11.5.5. Specimen Management & Storage
11.5.6. Special Chemistry Services
11.5.7. Clinical Research & Trial Services
11.5.8. Others
11.6. Asia Pacific Central Lab Market Value Share and Attractiveness Analysis, by End-user
11.7. Asia Pacific Central Lab Market Forecast, by End-user
11.7.1. Pharmaceutical Companies
11.7.2. Biotechnology Companies
11.7.3. Academic & Research Institutes

12. Latin America Central Lab Market Analysis
12.1. Latin America Central Lab Market Overview
12.2. Latin America Central Lab Market Value Share and Attractiveness Analysis, by Country/Sub-region
12.3. Latin America Central Lab Market Forecast, by Country/Sub-region
12.3.1. Brazil
12.3.2. Mexico
12.3.3. Rest of Latin America
12.4. Latin America Central Lab Market Value Share and Attractiveness Analysis, by Product
12.5. Latin America Central Lab Market Forecast, by Product
12.5.1. Genetic Services
12.5.2. Biomarker Services
12.5.3. Microbiology Services
12.5.4. Anatomic Pathology/Histology
12.5.5. Specimen Management & Storage
12.5.6. Special Chemistry Services
12.5.7. Clinical Research & Trial Services
12.5.8. Others
12.6. Latin America Central Lab Market Value Share and Attractiveness Analysis, by End-user
12.7. Latin America Central Lab Market Forecast, by End-user
12.7.1. Pharmaceutical Companies
12.7.2. Biotechnology Companies
12.7.3. Academic & Research Institutes

13. Middle East & Africa Central Lab Market Analysis
13.1. Middle East & Africa Central Lab Market Overview
13.2. Middle East & Africa Central Lab Market Value Share and Attractiveness Analysis, by Country/Sub-region
13.3. Middle East & Africa Central Lab Market Forecast, by Country/Sub-region
13.3.1. GCC Countries
13.3.2. South Africa
13.3.3. Rest of Middle East & Africa
13.4. Middle East & Africa Central Lab Market Value Share and Attractiveness Analysis, by Product
13.5. Middle East & Africa Central Lab Market Forecast, by Product
13.5.1. Genetic Services
13.5.2. Biomarker Services
13.5.3. Microbiology Services
13.5.4. Anatomic Pathology/Histology
13.5.5. Specimen Management & Storage
13.5.6. Special Chemistry Services
13.5.7. Clinical Research & Trial Services
13.5.8. Others
13.6. Middle East & Africa Central Lab Market Value Share and Attractiveness Analysis, by End-user
13.7. Middle East & Africa Central Lab Market Forecast, by End-user
13.7.1. Pharmaceutical Companies
13.7.2. Biotechnology Companies
13.7.3. Academic & Research Institutes
14. Competition Landscape
14.1. Competition Matrix
14.2. Company Share Analysis, 2019
14.3. Company Profiles
14.3.1. ACM Global Central Lab
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Strategic Overview
14.3.2. Barc Lab (Cerba Research)
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Strategic Overview
14.3.3. Bioscientia (Sonic Healthcare)
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Financial Overview
14.3.3.3. Product Portfolio
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. Celerion
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Strategic Overview
14.3.5. CIRION BioPharma Research
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Strategic Overview
14.3.6. Clinical Reference Laboratory
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Strategic Overview
14.3.7. Lab Corp/Covance
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Financial Overview
14.3.7.3. Product Portfolio
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. Eurofins Central Laboratory
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Financial Overview
14.3.8.3. Product Portfolio
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. Frontage Laboratories, Inc.
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Financial Overview
14.3.9.3. Product Portfolio
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
14.3.10. ICON Central Labs.
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Financial Overview
14.3.10.3. Product Portfolio
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview
14.3.11. INTERLAB Central Lab Services.
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Product Portfolio
14.3.11.3. SWOT Analysis
14.3.11.4. Strategic Overview
14.3.12. InVitro International
14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.12.2. Financial Overview
14.3.12.3. Product Portfolio
14.3.12.4. SWOT Analysis
14.3.12.5. Strategic Overview
14.3.13. LabConnect
14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.13.2. Product Portfolio
14.3.13.3. SWOT Analysis
14.3.13.4. Strategic Overview
14.3.14. Medpace
14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.14.2. Financial Overview
14.3.14.3. Product Portfolio
14.3.14.4. SWOT Analysis
14.3.14.5. Strategic Overview
14.3.15. MLM Medical Labs GmbH.
14.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.15.2. Product Portfolio
14.3.15.3. SWOT Analysis
14.3.15.4. Strategic Overview
14.3.16. PPD
14.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.16.2. Product Portfolio
14.3.16.3. SWOT Analysis
14.3.16.4. Strategic Overview
14.3.17. Q? Solutions
14.3.17.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.17.2. Product Portfolio
14.3.17.3. SWOT Analysis
14.3.17.4. Strategic Overview
14.3.18. Synevo Central Lab
14.3.18.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.18.2. Product Portfolio
14.3.18.3. SWOT Analysis
14.3.18.4. Strategic Overview



List of Figures




Figure 01: Global Central Lab Market Value (US$ Mn) Forecast, 2018–2030

Figure 02: Global Central Lab Market Value Share, by Product (2019)

Figure 03: Global Central Lab Market Value Share, by End-user (2019)

Figure 04: Global Central Lab Market Value Share, by Region (2019)

Figure 05: Global Central Lab Market Value Share Analysis, by Product, 2019 and 2030

Figure 06: Global Central Lab Market Revenue (US$ Mn), by Genetic Services, 2018–2030

Figure 07: Global Central Lab Market Revenue (US$ Mn), by Biomarker Services, 2018–2030

Figure 08: Global Central Lab Market Revenue (US$ Mn), by Microbiology Services, 2018–2030

Figure 09: Global Central Lab Market Revenue (US$ Mn), by Anatomic Pathology/Histology, 2018–2030

Figure 10: Global Central Lab Market Revenue (US$ Mn), by Specimen Management & Storage, 2018–2030

Figure 11: Global Central Lab Market Revenue (US$ Mn), by Special Chemistry Services, 2018–2030

Figure 12: Global Central Lab Market Revenue (US$ Mn), by Clinical Research & Trial Services, 2018–2030

Figure 13: Global Central Lab Market Revenue (US$ Mn), by Others, 2018–2030

Figure 14: Global Central Lab Market Attractiveness Analysis, by Product, 2020–2030

Figure 15: Global Central Lab Market Value Share Analysis, by End-user, 2019 and 2030

Figure 16: Global Central Lab Market Revenue (US$ Mn), by Pharmaceutical Companies, 2018–2030

Figure 17: Global Central Lab Market Revenue (US$ Mn), by Biotechnology Companies, 2018–2030

Figure 18: Global Central Lab Market Revenue (US$ Mn), by Academic & Research Institutes, 2018–2030

Figure 19: Global Central Lab Market Attractiveness Analysis, by End-user, 2020–2030

Figure 20: Global Central Lab Market Value Share Analysis, by Region, 2019 and 2030

Figure 21: Global Central Lab Market Analysis, by Region

Figure 22: North America Central Lab Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 23: North America Central Lab Market Value Share (%), by Country, 2019 and 2030

Figure 24: North America Central Lab Market Attractiveness Analysis, by Country, 2020–2030

Figure 25: North America Central Lab Market Value Share Analysis, by Product, 2019 and 2030

Figure 26: North America Central Lab Market Attractiveness Analysis, by Product, 2020–2030

Figure 27: North America Central Lab Market Value Share Analysis, by End-user, 2019 and 2030

Figure 28: North America Central Lab Market Attractiveness Analysis, by End-user, 2020–2030

Figure 29: Europe Central Lab Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 30: Europe Central Lab Market Value Share (%), by Countries/Sub-region, 2019 and 2030

Figure 31: Europe Central Lab Market Attractiveness Analysis, by Countries/Sub-region, 2020–2030

Figure 32: Europe Central Lab Market Value Share Analysis, by Product, 2019 and 2030

Figure 33: Europe Central Lab Market Attractiveness Analysis, by Product, 2020–2030

Figure 34: Europe Central Lab Market Value Share Analysis, by End-user, 2019 and 2030

Figure 35: Europe Central Lab Market Attractiveness Analysis, by End-user, 2020–2030

Figure 36: Asia Pacific Central Lab Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 37: Asia Pacific Central Lab Market Value Share (%), by Countries/Sub-region, 2019 and 2030

Figure 38: Asia Pacific Central Lab Market Attractiveness Analysis, by Countries/Sub-region, 2020–2030

Figure 39: Asia Pacific Central Lab Market Value Share Analysis, by Product, 2019 and 2030

Figure 40: Asia Pacific Central Lab Market Attractiveness Analysis, by Product, 2020–2030

Figure 41: Asia Pacific Central Lab Market Value Share Analysis, by End-user, 2019 and 2030

Figure 42: Asia Pacific Central Lab Market Attractiveness Analysis, by End-user, 2020–2030

Figure 43: Latin America Central Lab Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 44: Latin America Central Lab Market Value Share (%), by Countries/Sub-region, 2019 and 2030

Figure 45: Latin America Central Lab Market Attractiveness Analysis, by Countries/Sub-region, 2020–2030

Figure 46: Latin America Central Lab Market Value Share Analysis, by Product, 2019 and 2030

Figure 47: Latin America Central Lab Market Attractiveness Analysis, by Product, 2020–2030

Figure 48: Latin America Central Lab Market Value Share Analysis, by End-user, 2019 and 2030

Figure 49: Latin America Central Lab Market Attractiveness Analysis, by End-user, 2020–2030

Figure 50: Middle East & Africa Central Lab Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 51: Middle East & Africa Central Lab Market Value Share (%), by Countries/Sub-region, 2019 and 2030

Figure 52: Middle East & Africa Central Lab Market Attractiveness Analysis, by Countries/Sub-region, 2020–2030

Figure 53: Middle East & Africa Central Lab Market Value Share Analysis, by Product, 2019 and 2030

Figure 54: Middle East & Africa Central Lab Market Attractiveness Analysis, by Product, 2020–2030

Figure 55: Middle East & Africa Central Lab Market Value Share Analysis, by End-user, 2019 and 2030

Figure 56: Middle East & Africa Central Lab Market Attractiveness Analysis, by End-user, 2020–2030

Figure 57: ACM Global Laboratories Business Overview, Strategic Overview, SWOT Analysis

Figure 58: Barc Lab’s Business Overview, Strategic Overview, and SWOT Analysis

Figure 59: Bioscientia (Sonic Healthcare) Business Overview

Figure 60: Bioscientia (Sonic Healthcare) Financial Status (revenue, net sales and net profit)

Figure 61: Bioscientia (Sonic Healthcare) Strategic Overview, SWOT Analysis

Figure 62: Celerion’s Business Overview, Strategic Overview, and SWOT Analysis

Figure 63: CIRION BioPharma Research’s Business Overview, Strategic Overview and SWOT Analysis

Figure 64: Clinical Reference Laboratory’s Business Overview, Strategic Overview, and SWOT Analysis

Figure 65: Lab Corp/Covance’s Business Overview

Figure 66: Lab Corp/Covance’s Financial Status (revenue, net sales and net profit)

Figure 67: Lab Corp/Covance’s Strategic Overview, SWOT Analysis

Figure 68: Eurofins Central Laboratory’s Business Overview

Figure 69: Eurofins Central Laboratory Financial Status (revenue, Y-o-Y growth (%), net sales and profit)

Figure 70: Eurofins Central Laboratory’s Strategic Overview, SWOT Analysis

Figure 71: Frontage Laboratories’ Business Overview

Figure 72: Frontage Laboratories Financial Status (revenue, Y-o-Y growth (%), net sales and net profit)

Figure 73: Frontage Laboratories’ Strategic Overview, SWOT Analysis

Figure 74: ICON Central Labs Business Overview

Figure 75: ICON Central Labs Financial Status (revenue, Y-o-Y growth (%), net sales and net profit)

Figure 76: ICON Central Labs Strategic Overview, SWOT Analysis

Figure 77: InterLab Research Laboratory’s Business Overview, Strategic Overview and SWOT Analysis

Figure 78: InVitro International’s Business Overview

Figure 79: InVitro International’s Financial Status (revenue, Y-o-Y growth (%), net sales and net profit)

Figure 80: InVitro International’s Strategic Overview, SWOT Analysis

Figure 81: LabConnect Business Overview, Strategic Overview, SWOT Analysis

Figure 82: Medpace’s Business Overview

Figure 83: Medpace’s Financial Status (revenue, Y-o-Y growth (%), net sales and net profit)

Figure 84: Medpace’s Strategic Overview, SWOT Analysis.


List of Tables



List of Tables

Table 01: Global Central Lab Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 02: Global Central Lab Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 03: Global Central Lab Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 04: North America Central Lab Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 05: North America Central Lab Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 06: North America Central Lab Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 07: Europe Central Lab Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 08: Europe Central Lab Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 09: Europe Central Lab Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 10: Asia Pacific Central Lab Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 11: Asia Pacific Central Lab Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 12: Asia Pacific Central Lab Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 13: Latin America Central Lab Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 14: Latin America Central Lab Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 15: Latin America Central Lab Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 16: Middle East & Africa Central Lab Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 17: Middle East & Africa Central Lab Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 18: Middle East & Africa Central Lab Market Value (US$ Mn) Forecast, by End-user, 2018–2030